Atlas Trials

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

Clinical trial NCT05434689 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05434689
Sponsor
University of Alabama at Birmingham
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2023-01-18
Primary completion
2028-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.